Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-27 | Wendy L. Yarno joined our Board in December 2017 and qualifies to serve on our Board as a result of her years of experience in the pharmaceutical industry. Ms. Yarno retired in September 2008 from Merck & Company, Inc. following a 26-year career in commercial and human resource positions of increasing seniority, most recently as Chief Marketing Officer before she retired. Ms. Yarno also spent part of her career at Johnson & Johnson, Inc. in commercial positions. Ms. Yarno currently serves on the boards of directors of the publicly traded companies Global Blood Therapeutics, Inc., MyoKardia, Inc. and Ideaya Biosciences, Inc. Within the last five years, Ms. Yarno served on the board of directors of Alder Biopharmaceuticals, Inc., Aratana Therapeutics, Inc., Medivation, Inc. and St. Jude Medical, Inc. Ms. Yarno holds a B.S. in Business Administration from Portland State University and an M.B.A. from Temple University. |
| 2021-03-25 | Wendy L. Yarno joined our Board in December 2017 and qualifies to serve on our Board as a result of her years of experience in the pharmaceutical industry. Ms. Yarno retired in September 2008 from Merck & Company, Inc. following a 26-year career in commercial and human resource positions of increasing seniority, most recently as Chief Marketing Officer before she retired. Ms. Yarno also spent part of her career at Johnson & Johnson, Inc. in commercial positions. Ms. Yarno currently serves on the boards of directors of the publicly traded companies Global Blood Therapeutics, Inc., Ideaya Biosciences, Inc. and Tarsus Pharmaceuticals. Within the last five years, Ms. Yarno served on the board of directors of MyoKardia, Inc., Alder Biopharmaceuticals, Inc., Aratana Therapeutics, Inc., Medivation, Inc. and St. Jude Medical, Inc. Ms. Yarno holds a B.S. in Business Administration from Portland State University and an M.B.A. from Temple University. |
| 2022-03-25 | Wendy L. Yarno Age: 67 Director Since: 2017 Director The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller, Jay P. Shepard and Lota S. Zoth. The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Wendy L. Yarno Fees Earned or Paid in Cash ($): 75,500 Stock Awards ($): 112,140 Option Awards ($): 124,805 Total ($): 312,445 |
| 2023-03-28 | Wendy L. Yarno Age: 68 Director Since: 2017 Director The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller, Jay P. Shepard and Lota S. Zoth. The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Wendy L. Yarno Fees Earned or Paid in Cash ($): 82,500 Stock Awards ($): 35,910 Option Awards ($): 40,434 Total ($): 158,844 |
| 2023-11-28 | Directors and Named Executive Officers: Wendy L. Yarno |
| 2024-04-11 | Wendy L. Yarno Age: 69 Director Since: 2017 The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller and Lota S. Zoth. The members of the Nomination and Corporate Governance Committee currently are Simon X. Benito (Chair), Roger D. Dansey, Jay P. Shepard and Wendy L. Yarno. Director Compensation Table Wendy L. Yarno Fees Earned or Paid in Cash ($): 82,500 Stock Awards ($): 20,014 Option Awards ($): 21,171 Total ($): 123,685 |
| 2025-04-07 | Wendy L. Yarno, Age: 70, Director. Committee: Compensation Committee (Chair). Total compensation: $132,341. |
Data sourced from SEC filings. Last updated: 2026-03-05